Astria Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Astria Therapeutics, Inc. (ATXS) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents59.82246.5320.5386.5124.9336.2437.57
Short-Term Investments268.3171.00205.9139.0020.000.000.00
Cash & Short-Term Investments328.13246.53226.44125.5144.9336.2437.57
Accounts Receivable0.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets6.514.411.251.571.400.000.00
Total Current Assets334.64250.94227.69127.0846.3338.9638.92
Non-Current Assets
Property, Plant & Equipment (Net)5.115.800.950.390.972.350.00
Other Non-Current Assets2.613.362.000.050.170.470.25
Total Non-Current Assets7.729.162.940.441.132.820.25
Total Assets342.36254.67230.63127.5147.4641.7839.17
Current Liabilities
Accounts Payable4.3211.220.791.561.542.442.76
Short-Term Debt1.380.000.000.000.000.000.00
Accrued Liabilities8.345.664.321.324.200.000.00
Other Current Liabilities13.434.053.371.960.000.000.00
Total Current Liabilities19.1311.559.065.206.395.034.17
Non-Current Liabilities
Long-Term Debt3.970.000.360.000.401.030.00
Other Non-Current Liabilities0.000.000.000.000.000.000.06
Total Non-Current Liabilities3.970.000.360.000.401.030.06
Total Liabilities23.1011.559.425.206.796.064.23
Stockholders' Equity
Common Stock0.060.040.030.010.000.000.00
Retained Earnings-674.79-580.53-507.64-455.81-260.90-223.60-197.30
Accumulated Other Comprehensive Income0.160.00-0.080.000.000.000.00
Additional Paid-in Capital898.51728.29632.51481.71301.56259.31232.24
Shares Outstanding56.4341.0327.5013.020.000.000.00
Total Stockholders' Equity319.26147.79221.22122.3140.6735.7234.94
Total Liabilities & Equity342.36254.67230.63127.5147.4641.7839.17